• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

oig

  1. OIG visits Cambridge

    Saw where officers from oig visited Cambridge. Interesting Does not look good.
  2. Pathnostics Study Funneling Money to Doctors?

    Did I hear correctly that Pathnostics is offering big bucks to doctors in exchange for UTI specimens in a thinly veiled kickback attempt? 110,000 study participants to show PCR works for UTI detection: https://clinicaltrials.gov/ct2/show/NCT04108910?term=pathnostics&draw=2&rank=2 Reminds one...